The DOI matches its Crossref record; 142 of the 145 references it cites were found in a registry or an index.
Cytology versus HPV testing for cervical cancer screening in the general population
Open accessAbstract
BACKGROUND: Cervical cancer screening has traditionally been based on cervical cytology. Given the aetiological relationship between human papillomavirus (HPV) infection and cervical carcinogenesis, HPV testing has been proposed as an alternative screening test. OBJECTIVES: To determine the diagnostic accuracy of HPV testing for detecting histologically confirmed cervical intraepithelial neoplasias (CIN) of grade 2 or worse (CIN 2+), including adenocarcinoma in situ, in women participating in primary cervical cancer screening; and how it compares to the accuracy of cytological testing (liquid-based and conventional) at various thresholds. SEARCH METHODS: We performed a systematic literature search of articles in MEDLINE and Embase (1992 to November 2015) containing quantitative data and handsearched the reference lists of retrieved articles. SELECTION CRITERIA: We included comparative test accuracy studies if all women received both HPV testing and cervical cytology followed by verification of the disease status with the reference standard, if positive for at least one screening test. The studies had to include women participating in a cervical cancer screening programme who were not being followed up for previous cytological abnormalities. DATA COLLECTION AND ANALYSIS: We completed a 2 x 2 table with the number of true positives (TP), false positives (FP), true negatives (TN), and false negatives for each screening test (HPV test and cytology) used in each study. We calculated the absolute and relative sensitivities and the specificities of the tests for the detection of CIN 2+ and CIN 3+ at various thresholds and computed sensitivity (TP/(TP + TN) and specificity (TN/ (TN + FP) for each test separately. Relative sensitivity and specificity of one test compared to another test were defined as sensitivity of test-1 over sensitivity of test-2 and specificity of test-1 over specificity of test-2, respectively. To assess bias in the studies, we used the Quality Assessment of Diagnostic test Accuracy Studies (QUADAS) tool. We used a bivariate random-effects model for computing pooled accuracy estimates. This model takes into account the within- and between-study variability and the intrinsic correlation between sensitivity and specificity. MAIN RESULTS: We included a total of 40 studies in the review, with more than 140,000 women aged between 20 and 70 years old. Many studies were at low risk of bias. There were a sufficient number of included studies with adequate methodology to perform the following test comparisons: hybrid capture 2 (HC2) (1 pg/mL threshold) versus conventional cytology (CC) (atypical squamous cells of undetermined significance (ASCUS)+ and low-grade squamous intraepithelial lesions (LSIL)+ thresholds) or liquid-based cytology (LBC) (ASCUS+ and LSIL+ thresholds), other high-risk HPV tests versus conventional cytology (ASCUS+ and LSIL+ thresholds) or LBC (ASCUS+ and LSIL+ thresholds). For CIN 2+, pooled sensitivity estimates for HC2, CC and LBC (ASCUS+) were 89.9%, 62.5% and 72.9%, respectively, and pooled specificity estimates were 89.9%, 96.6%, and 90.3%, respectively. The results did not differ by age of women (less than or greater than 30 years old), or in studies with verification bias. Accuracy of HC2 was, however, greater in European countries compared to other countries. The results for the sensitivity of the tests were heterogeneous ranging from 52% to 94% for LBC, and 61% to 100% for HC2. Overall, the quality of the evidence for the sensitivity of the tests was moderate, and high for the specificity.The relative sensitivity of HC2 versus CC for CIN 2+ was 1.52 (95% CI: 1.24 to 1.86) and the relative specificity 0.94 (95% CI: 0.92 to 0.96), and versus LBC for CIN 2+ was 1.18 (95% CI: 1.10 to 1.26) and the relative specificity 0.96 (95% CI: 0.95 to 0.97). The relative sensitivity of HC2 versus CC for CIN 3+ was 1.46 (95% CI: 1.12 to 1.91) and the relative specificity 0.95 (95% CI: 0.93 to 0.97). The relative sensitivity of HC2 versus LBC for CIN 3+ was 1.17 (95% CI: 1.07 to 1.28) and the relative specificity 0.96 (95% CI: 0.95 to 0.97). AUTHORS' CONCLUSIONS: Whilst HPV tests are less likely to miss cases of CIN 2+ and CIN 3+, these tests do lead to more unnecessary referrals. However, a negative HPV test is more reassuring than a negative cytological test, as the cytological test has a greater chance of being falsely negative, which could lead to delays in receiving the appropriate treatment. Evidence from prospective longitudinal studies is needed to establish the relative clinical implications of these tests.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Third, a proportion of screened women with cervical precancer and cancer show false negative Pap tests.18 19”
From Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses (2018) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“HPV-based cervical cancer screening is widely used and has superior sensitivity and negative predictive value compared with cytology screening tests [7].”
From Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping (2022) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,762
Whiting, P., Rutjes, A. W., Reitsma, J. B., Bossuyt, P. M., & Kleijnen, J. (2003) · BMC Medical Research Methodology · doi:10.1186/1471-2288-3-25 · Cited by 3,592
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A. T., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,587
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Principles and Practice of Screening for Disease.
(1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-5-1085_2 · Cited by 3,251
Human papillomavirus and cervical cancer
SCHIFFMAN, M. H., Castle, P. E., Jerónimo, J., Rodríguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 3,135
The 2001 Bethesda System<SUBTITLE>Terminology for Reporting Results of Cervical Cytology</SUBTITLE>
Solomon, D. (2002) · JAMA · doi:10.1001/jama.287.16.2114 · Cited by 3,104
Deeks, J. J., Macaskill, P., & Irwig, L. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.016 · Cited by 2,910
Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J. F., Arbyn, M., Kitchener, H., Segnan, N., Gilham, C., Giorgi-Rossi, P., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62218-7 · Cited by 1,810
Self-citationA hierarchical regression approach to meta‐analysis of diagnostic test accuracy evaluations
Rutter, C. M., & Gatsonis, C. (2001) · Statistics in Medicine · doi:10.1002/sim.942 · Cited by 1,510
The Pap Test and Bethesda 2014
Nayar, R., & Wilbur, D. C. (2015) · Journal of the American Society of Cytopathology · doi:10.1016/j.jasc.2015.03.003 · Cited by 1,149
Worldwide burden of cervical cancer in 2008
Arbyn, M., Castellsagué, X., de Sanjosé, S., Bruni, L., Saraiya, M., Bray, F., & Ferlay, J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr015 · Cited by 1,147
Self-citationMcCredie, M. R. E., SHARPLES, K. J., Paul, C., Baranyai, J., Medley, G., Jones, R. W., & Skegg, D. C. G. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70103-7 · Cited by 1,128
Stoler, M. H. (2001) · JAMA · doi:10.1001/jama.285.11.1500 · Cited by 1,087
Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
Arbyn, M., Ronco, G., Anttila, A., Meijer, C. J. L. M., Poljak, M., Ogilvie, G., Koliopoulos, G., Naucler, P., Sankaranarayanan, R., & Peto, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.095 · Cited by 897
Self-citation2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests
Wright, T. C., Massad, L. S., Dunton, C. J., Spitzer, M., Wilkinson, E. J., & Solomon, D. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.07.047 · Cited by 829
Saslow, D., Solomon, D., Lawson, H. W., Killackey, M. A., Kulasingam, S., Cain, J. M., García, F., Moriarty, A. T., Waxman, A. G., Wilbur, D. C., et al. (2012) · American Journal of Clinical Pathology · doi:10.1309/ajcptgd94evrsjcg · Cited by 810
Arbyn, M., Anttila, A., Jordan, J. A., Ronco, G., Schenck, U., Segnan, N., Wiener, H., Herbert, A., & von Karsa, L. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp471 · Cited by 762
Self-citationChu, H., & Cole, S. R. (2006) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2006.06.011 · Cited by 708
Läärä, E., Day, N. E., & Hakama, M. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92695-x · Cited by 662
The Diagnostic Value of Vaginal Smears in Carcinoma of the Uterus
Papanicolaou, G. N., & Traut, H. F. (1941) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)40621-6 · Cited by 622
Katki, H. A., Kinney, W., Fetterman, B. J., Lorey, T. S., Poitras, N. E., Cheung, L. C., Demuth, F., SCHIFFMAN, M. H., Wacholder, S., & Castle, P. E. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70145-0 · Cited by 581
Quinn, M. A., Babb, P., Jones, J., & Allen, E. (1999) · BMJ · doi:10.1136/bmj.318.7188.904 · Cited by 571
Chapter 9: Clinical applications of HPV testing: A summary of meta-analyses
Arbyn, M., Sasieni, P. D., Meijer, C. J. L. M., Clavel, C., Koliopoulos, G., & Dillner, J. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.117 · Cited by 541
Self-citationSchiffman, M., Herrero, R., Hildesheim, A., Sherman, M. E., Bratti, M., Wacholder, S., Alfaro, M., Hutchinson, M., Morales, J., Greenberg, M. D., et al. (2000) · JAMA · doi:10.1001/jama.283.1.87 · Cited by 540
Castle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 537
Management of women who test positive for high-risk types of human papillomavirus: the HART study
Cuzick, J., Szarewski, A., Cubie, H., Hulman, G., Kitchener, H., Luesley, D., McGoogan, E., Menon, U., Terry, G., Edwards, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14955-0 · Cited by 510
Qiao, Y.-L., Sellors, J. W., Eder, P. S., Bao, Y.-P., Lim, J. M., Zhao, F.-H., Weigl, B., Zhang, W.-H., Peck, R. B., Li, L., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70210-9 · Cited by 471
Clavel, C., Masure, M., Bory, J. P., Putaud, I., Mangeonjean, C., Lorenzato, M., Nazeyrollas, P., Gabriel, R., Quéreux, C., & Birembaut, P. L. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1845 · Cited by 461
Evaluation of Human Papillomavirus Testing in Primary Screening for Cervical Abnormalities
Kulasingam, S., Hughes, J. P., Kiviat, N. B., Mao, C., Weiss, N. S., Kuypers, J. M., & Koutsky, L. A. (2002) · JAMA · doi:10.1001/jama.288.14.1749 · Cited by 452
Sherman, M. E., Lorincz, A. T., Scott, D. R., Wacholder, S., Castle, P. E., Glass, A. G., Mielzynska, I., Rush, B. B., & SCHIFFMAN, M. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.46 · Cited by 429
Management of women who test positive for high-risk types of human papillomavirus: the HART study
(2004) · Obstetrics and Gynecology · doi:10.1097/00006250-200404000-00038 · Cited by 427
PHAGOCYTOSIS IN CHRONIC GRANULOMATOUS DISEASE
GAST, G. C. D., Ydema, W., Wiersma, M., & Dankert, J. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92245-x · Cited by 361
Arbyn, M., Buntinx, F., Ranst, M. A. V., Paraskevaidis, E. A., Martin‐Hirsch, P. L., & Dillner, J. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh037 · Cited by 357
Self-citationTHE INVASIVE POTENTIAL OF CARCINOMA IN SITU OF THE CERVIX
McIndoe, W. A. (1979) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197911000-00044 · Cited by 342
Belinson, J. L., Qiao, Y., Pretorius, R. G., Zhang, W., Elson, P. J., Li, L., Pan, Q. J., Fischer, C., Lorincz, A. T., & Zahniser, D. J. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6370 · Cited by 337
Human papillomavirus testing in primary cervical screening
Cuzick, J. M., Szarewski, A., Terry, G., Hanby, A. M., Maddox, P., Anderson, M., Steele, S. J., Guillebaud, J., & Kocjean, C. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91086-7 · Cited by 328
Arbyn, M., Sankaranarayanan, R., Muwonge, R., Keita, N., Dolo, A., Mbalawa, C. G., Nouhou, H., Sakandé, B., Wesley, R. S., Somanathan, T., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23489 · Cited by 318
Self-citationRonco, G., Segnan, N., Rossi, P. G., Zappa, M., Casadei, G. P., Carozzi, F., Palma, P. D., Mistro, A. D., Folicaldi, S., Gillio‐Tos, A., et al. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj209 · Cited by 312
Benefits and Costs of Using HPV Testing to Screen for Cervical Cancer
Mandelblatt, J. S. (2002) · JAMA · doi:10.1001/jama.287.18.2372 · Cited by 302
Petry, K. U., Menton, S., Menton, M., van Loenen-Frosch, F., Gomes, H. D. C., Holz, B., Schopp, B., Garbrecht-Buettner, S., Davies, P. O., Boehmer, G., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600918 · Cited by 300
Trends of cervical cancer mortality in the member states of the European Union
Arbyn, M., Raifu, A. O., Weiderpass, E., Bray, F., & Anttila, A. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2009.07.018 · Cited by 298
Self-citationNauclér, P., Ryd, W., Törnberg, S., Strand, A., Wadell, G., Elfgren, K., Rådberg, T., Strander, B., Forslund, O., Hansson, B. G., et al. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn444 · Cited by 287
HPV testing in primary screening of older women
Cuzick, J. M., Beverley, E., Ho, L., Terry, G., Sapper, H., Mielzynska, I., Lorincz, A. T., Chan, W.-K., Krausz, T. N., & Soutter, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690730 · Cited by 267
Process of care failures in invasive cervical cancer: Systematic review and meta-analysis
Spence, A. R., Goggin, P., & Franco, E. L. (2007) · Preventive Medicine · doi:10.1016/j.ypmed.2007.06.007 · Cited by 261
Evaluation of alternative methods of cervical cancer screening for resource-poor settings
Denny, L., Kuhn, L., Pollack, A. E., Wainwright, H., & Wright, T. C. (2000) · Cancer · doi:10.1002/1097-0142(20000815)89:4 · Cited by 250
The serological response to papillomaviruses
Dillner, J. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1999.0146 · Cited by 235
Multiple Biopsies and Detection of Cervical Cancer Precursors at Colposcopy
Wentzensen, N., Walker, J. L., Gold, M. A., Smith, K., Zuna, R. E., Mathews, C. A., Dunn, S. T., Zhang, R., Moxley, K. M., Bishop, E. A., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.9948 · Cited by 230
Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings
Kuhn, L., Denny, L., Pollack, A., Lorincz, A., Richart, R. M., & Wright, T. C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.818 · Cited by 217
Cervical cancer screening programmes and policies in 18 European countries
Anttila, A., Ronco, G., Clifford, G. M., Bray, F., Hakama, M., Arbyn, M., & Weiderpass, E. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602069 · Cited by 216
Self-citationHuman papillomavirus testing for primary screening of cervical cancer precursors.
Ratnam, S., Franco, E. L., & Ferenczy, A. S. (2000) · PubMed · Cited by 210
Sankaranarayanan, R., Nene, B. M., Dinshaw, K. A., Mahe, C., Jayant, K., Shastri, S. S., Malvi, S. G., Chinoy, R., Kelkar, R., Budukh, A. M., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21050 · Cited by 206
Evaluation of 14 triage strategies for HPV DNA‐positive women in population‐based cervical screening
Rijkaart, D., Berkhof, J. H., van Kemenade, F. J., Coupé, V. M. H., Hesselink, A. T., Rozendaal, L., Heideman, D. A. M., Verheijen, R. H., Bulk, S., Verweij, W. M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26056 · Cited by 205
McCaffery, K. J., Waller, J., Forrest, S., Cadman, L., Szarewski, A., & Wardle, J. (2004) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00279.x · Cited by 200
Jerónimo, J., & SCHIFFMAN, M. H. (2006) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.01.091 · Cited by 200
Coste, J., Cochand‐Priollet, B., de Crémoux, P., Galès, C. L., Cartier, I., Molinié, V., Labbé, S., Vacher‐Lavenu, M., & Vielh, P. R. (2003) · BMJ · doi:10.1136/bmj.326.7392.733 · Cited by 181
Kitchener, H. C., Gilham, C., Sargent, A., Bailey, A. C., Albrow, R., Roberts, C., Desai, M., Mather, J., Turner, A. J., Moss, S., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.01.008 · Cited by 175
Jordan, J. A., Arbyn, M., Martin‐Hirsch, P. L., Schenck, U., Jj, B., Silva, D. D., Anttila, A., Nieminen, P., & Prendiville, W. J. (2008) · Cytopathology · doi:10.1111/j.1365-2303.2008.00623.x · Cited by 167
Self-citationZhao, F.-H., Lin, M. J., Chen, F., Hu, S.-Y., Zhang, R., Belinson, J. L., Sellors, J. W., Franceschi, S., Qiao, Y.-L., & Castle, P. E. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70256-4 · Cited by 158
Kawesha, A., Ghaneh, P., Andrén‐Sandberg, Å., Ögraed, D., Skar, R., Dawiskiba, S., Evans, J. D., Campbell, F., Lemoine, N. R., & Neoptolemos, J. P. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001120)89:6 · Cited by 152
Dai, M., Bao, Y., Li, N., Clifford, G. M., Vaccarella, S., Snijders, P. J. F., Huang, R. D., Sun, L., Meijer, C. J. L. M., Qiao, Y., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603208 · Cited by 150
Monsonégo, J., Hudgens, M. G., Zerat, L., Zerat, J., Syrjänen, K. J., Halfon, P., Ruiz, F., & Smith, J. S. (2010) · International Journal of Cancer · doi:10.1002/ijc.25726 · Cited by 150
Sarian, L. O., Derchain, S., Naud, P., Roteli-Martins, C. M., Longatto‐Filho, A., Tatti, S., Branca, M., Eržen, M., Hammes, L. S., Matos, J., et al. (2005) · Journal of Medical Screening · doi:10.1258/0969141054855328 · Cited by 144
Belinson, J. L., Qiao, Y., Pretorius, R. G., Zhang, W. H., Rong, S. D., Huang, M., Zhao, F., Wu, L., Ren, S., Huang, R., et al. (2003) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2003.13611.x · Cited by 141
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Αγοραστός, Θ., Chatzistamatiou, Κ., Katsamagkas, T., Koliopoulos, G., Daponte, A. I., Constantinidis, Τ., Constantinidis, T. C., & and the HERMES study group (2015) · PLoS ONE · doi:10.1371/journal.pone.0119755 · Cited by 139
Self-citationAn, H. J., Cho, N. H., Lee, S. Y., Kim, I. H., Lee, C. M., Kim, S. J., Mun, M. S., Kim, S. H., & Jeong, J. K. (2003) · Cancer · doi:10.1002/cncr.11235 · Cited by 139
Shastri, S., Dinshaw, K. A., Amin, G., Goswami, S., Patil, S. P., Chinoy, R., Kane, S., Kelkar, R. S., Muwonge, R., Mahé, C., et al. (2005) · Europe PMC (PubMed Central) · Cited by 139
Gravitt, P. E., Paul, P., Katki, H. A., Vendantham, H., Ramakrishna, G., Mrudula, S., Basany, K., Ronnett, B. M., Vijayaraghavan, K., Shah, K. V., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013711 · Cited by 137
Benevolo, M., Vocaturo, A., Caraceni, D., French, D., Rosini, S., Zappacosta, R., Terrenato, I., Ciccocioppo, L., Frega, A., & Rossi, P. G. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02570-10 · Cited by 135
Salmerón, J., Lazcano-Ponce, E. C., Lorincz, A. T., Hernández, M., Hernández, P., Leyva-López, A., Uribe, M., Manzanares, H., Antúnez, A., Carmona, E., et al. (2003) · Cancer Causes & Control · doi:10.1023/a:1024806707399 · Cited by 128
Sankaranarayanan, R., Chatterji, R., Shastri, S. S., Wesley, R. S., Basu, P., Mahe, C., Muwonge, R., Seigneurin, D., Somanathan, T., Roy, C., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20396 · Cited by 127
Schatzkin, A. G., Connor, R., Taylor, P. R., & Bunnag, B. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114580 · Cited by 112
Sigurðsson, K. (1999) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1034/j.1600-0412.1999.780602.x · Cited by 109
How to evaluate emerging technologies in cervical cancer screening?
Arbyn, M., Ronco, G., Cuzick, J. M., Wentzensen, N., & Castle, P. E. (2009) · International Journal of Cancer · doi:10.1002/ijc.24774 · Cited by 106
Self-citationNucleic Acid Tests for the Detection of Alpha Human Papillomaviruses
Poljak, M., Cuzick, J. M., Kocjan, B. J., Iftner, T., Dillner, J., & Arbyn, M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.105 · Cited by 106
Self-citationVuyst, H. D., Claeys, P., Njiru, S., Muchiri, L. W., Steyaert, S., Sutter, P. D., Marck, E. V., Bwayo, J. J., & Temmerman, M. (2005) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2005.01.035 · Cited by 104
Blumenthal, P. D., Gaffikin, L., Chirenje, Z. M., McGrath, J. A., Womack, S. D., & Shah, K. V. (2001) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)00329-5 · Cited by 103
HPV DNA testing in population-based cervical screening (VUSA-Screen study): results and implications
Rijkaart, D., Berkhof, J. H., van Kemenade, F. J., Coupé, V. M. H., Rozendaal, L., Heideman, D. A. M., Verheijen, R. H. M., Bulk, S., Verweij, W. M., Snijders, P. J. F., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.581 · Cited by 103
Improved sensitivity of vaginal self‐collection and high‐risk human papillomavirus testing
Belinson, J. L., Du, H., Yang, B., Wu, R., Belinson, S., Qu, X., Pretorius, R. G., Yi, X., & Castle, P. E. (2011) · International Journal of Cancer · doi:10.1002/ijc.26202 · Cited by 102
Iftner, T., Becker, S., Neis, K.-J., Castañón, A., Iftner, A., Holz, B., Staebler, A., Henes, M., Rall, K., Haedicke, J., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01013-15 · Cited by 95
Coquillard, G., Palao, B., & Patterson, B. K. (2010) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.09.013 · Cited by 93
Dijkstra, M. G., van Niekerk, D., Rijkaart, D., van Kemenade, F. J., Heideman, D. A. M., Snijders, P. J. F., Meijer, C. J. L. M., & Berkhof, J. H. (2013) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0173 · Cited by 92
Belinson, J. L., Hu, S., Niyazi, M., Pretorius, R. G., Wang, H., Chen, W., Smith, J. S., Li, J., Taddeo, F. J., Burchette, R. J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25144 · Cited by 86
Riethmuller, D., Gay, C., Bertrand, X., Bettinger, D., Schaal, J. P., Carbillet, J. P., Lassabe, C., Arveux, P., Seillès, E., & Mougin, C. (1999) · Diagnostic Molecular Pathology · doi:10.1097/00019606-199909000-00009 · Cited by 86
Accuracy of conventional cytology: results from a multicentre screening study in India
Sankaranarayanan, R., Thara, S., Sharma, A., Roy, C., Shastri, S. S., Mahé, C., Muwonge, R., & Fontanière, B. (2004) · Journal of Medical Screening · doi:10.1258/096914104774061056 · Cited by 79
de Crémoux, P., Coste, J., Sastre‐Garau, X., Thioux, M., Bouillac, C., Labbé, S., Cartier, I., Ziol, M., Dosda, A., Galès, C. L., et al. (2003) · American Journal of Clinical Pathology · doi:10.1309/xfuc-pp6m-5xua-94b8 · Cited by 78
Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe
Womack, S. D., Chirenje, Z. M., Blumenthal, P. D., Gaffikin, L., McGrath, J. A., Chipato, T., Ngwalle, E., & Shah, K. V. (2000) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2000.tb11576.x · Cited by 77
Bigras, G., & de Marval, F. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602728 · Cited by 75
Catterina Ferreccio, R., Bratti, M. C., Sherman, M. E., Herrero, R., Wacholder, S., Hildesheim, A., Burk, R. D., Hutchinson, M. L., Alfaro, M., Greenberg, M., et al. (2003) · PubMed · Cited by 72
Li, C., Wu, M., Wang, J., Zhang, S., Zhu, L. X., Pan, J., & Zhang, W. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0212 · Cited by 67
Efficiency of the Hybrid Capture 2 HPV DNA Test in Cervical Cancer Screening
de Crémoux, P., Coste, J., Sastre‐Garau, X., Thioux, M., Bouillac, C., Labbé, S., Cartier, I., Ziol, M., Dosda, A., Galès, C. L., et al. (2003) · American Journal of Clinical Pathology · doi:10.1309/xfucpp6m5xua94b8 · Cited by 65
Belinson, J. L., Wu, R., Belinson, S., Qu, X., Yang, B., Du, H., Wu, R., Wang, C., Zhang, L., Zhou, Y., et al. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpka6atapbz6jq · Cited by 61
Syrjänen, S., Shabalova, I. P., Петровичев, Н. Н., Kozachenko, V. P., Zakharova, T., Pajanidi, J., Podistov, J., Chemeris, G. Y., Sozaeva, L. G., Lipova, E., et al. (2002) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200204000-00006 · Cited by 60
Prior knowledge of HPV status improves detection of CIN2+ by cytology screening
Benoy, I. H., Broeck, D. V., Ruymbeke, M. J., Sahebali, S., Arbyn, M., Bogers, J., Temmerman, M., & Depuydt, C. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.101 · Cited by 58
Self-citationDepuydt, C., Benoy, I. H., Beert, J., Criel, A. M., Bogers, J., & Arbyn, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01231-12 · Cited by 56
Self-citationMesher, D., Szarewski, A., Cadman, L., Cubie, H., Kitchener, H. C., Luesley, D. M., Menon, U., Hulman, G., Desai, M., Ho, L., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605619 · Cited by 55
Monsonégo, J., Hudgens, M. G., Zerat, L., Zerat, J., Syrjänen, K. J., & Smith, J. S. (2012) · Gynecologic Oncology · doi:10.1016/j.ygyno.2012.01.002 · Cited by 54
Longatto‐Filho, A., Naud, P., Derchain, S., Roteli-Martins, C. M., Tatti, S., Hammes, L. S., Sarian, L. O., Eržen, M., Branca, M., de Matos, J. C., et al. (2012) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-012-1242-y · Cited by 54
Human Papillomavirus (HPV) Detection Using In Situ Hybridization in Histologic Samples
Kelesidis, T., Aish, L. S., Steller, M. A., Aish, I. S., Shen, J., Foukas, P. G., Panayiotides, J. G., Petrikkos, G. L., Karakitsos, P., & Tsiodras, S. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcp03huqyzmwatp · Cited by 54
Wu, R., Belinson, S., Du, H., Wulan, N., Qu, X., Wu, R., Liu, Y., Wang, C., Zhou, Y., Zhang, L., et al. (2010) · PubMed · doi:10.1111/igc.0b013e3181f29547 · Cited by 52
Screening trial of human papillomavirus for early detection of cervical cancer in Santiago, Chile
Catterina Ferreccio, R., Barriga, M. I., Marcela Lagos, L., Ibáñez, C., Helena Poggi, M., González, F., Terrazas, S., Katki, H. A., Núñez, F., Cartagena, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27662 · Cited by 49
Different cervical cancer screening approaches in a Chinese multicentre study
Li, N., Shi, J.-F., Franceschi, S., Zhang, W.-H., Dai, M., Liu, B., Zhang, Y.-Z., Li, L.-K., Wu, R.-F., Vuyst, H. D., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6604840 · Cited by 47
BD-ProExC as Adjunct Molecular Marker for Improved Detection of CIN2+ after HPV Primary Screening
Depuydt, C., Makar, A. P., Ruymbeke, M. J., Benoy, I. H., Vereecken, A. J., & Bogers, J. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0818 · Cited by 44
Nieminen, P., Vuorma, S., Viikki, M., Hakama, M., & Anttila, A. (2004) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00210.x · Cited by 42
Αγοραστός, Θ., Dinas, K. D., Lloveras, B., de Sanjosé, S., Kornegay, J., Bonti, H., Bosch, F. X., Constantinidis, T. C., & Bontis, J. N. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.11.042 · Cited by 42
Nieves, L., Enerson, C. L., Belinson, S., Brainard, J., Chiesa-Vottero, A. G., Nagore, N., Booth, C. N., Pérez, A. G., Chávez‐Avilés, M. N., & Belinson, J. L. (2013) · International Journal of Gynecological Cancer · doi:10.1097/igc.0b013e318280f3bc · Cited by 42
CareHPV cervical cancer screening demonstration in a rural population of north India
Labani, S., Asthana, S., Sodhani, P., Gupta, S. K., Bhambhani, S., Pooja, B., Lim, J., & Jerónimo, J. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.03.006 · Cited by 41
Hovland, S., Arbyn, M., Lie, A. K., Ryd, W., Börge, B., BERLE, E. J., Skomedal, H., Kadima, T. M., Kyembwa, L., Bilayi, E., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605594 · Cited by 36
Self-citationMoy, L. M., Zhao, F., Li, L., Ma, J., Zhang, Q., Chen, F., Song, Y., Hu, S., Balasubramanian, A., Pan, Q., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25071 · Cited by 35
Pan, Q., Belinson, J. L., Li, L., Pretorius, R. G., Qiao, Y., Zhang, W. H., Zhang, X., Wu, L. Y., Rong, S. D., & Sun, Y. T. (2003) · Acta Cytologica · doi:10.1159/000326474 · Cited by 34
de Andrade, A. C. V., Luz, P. M., Velasque, L. D. S., Veloso, V. G., Moreira, R. I., Russomano, F. B., Coelho, J. M. C. D. O., Pires, E., Levi, J. E., Grinsztejn, B. G. J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018297 · Cited by 32
Application of Human Papillomavirus in Screening for Cervical Cancer and Precancerous Lesions
Wang, J., Yang, Y., Dong, W., Sun, J., Tao, H., Li, R., & Hu, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.5.2979 · Cited by 30
Cárdenas-Turanzas, M., Nogueras‐González, G. M., Scheurer, M. E., Adler‐Storthz, K., Benedet, J. L., Beck, J. R., Follen, M. M., & Cantor, S. B. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0137 · Cited by 30
Costa, S., Sideri, M. G., Syrjänen, K. J., Terzano, P., Nuzzo, M. D., Simone, P. D., Cristiani, P., Finarelli, A. C., Bovicelli, A., Zamparelli, A., et al. (2000) · Acta Cytologica · doi:10.1159/000328471 · Cited by 29
Shipitsyna, E. V., Zolotoverkhaya, E. A., Александрович, К. Д., Nasonova, V., Romanyuk, T. N., Khachaturyan, A. R., Orlova, О. O., Ивановна, А. Е., Kostyuchek, I., Shipulina, O. Y., et al. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.08.010 · Cited by 29
Impact of Improved Classification on the Association of Human Papillomavirus With Cervical Precancer
Castle, P. E., Schiffman, M., Wheeler, C. M., Wentzensen, N., & Gravitt, P. E. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp390 · Cited by 28
Benevolo, M., Terrenato, I., Mottolese, M., Marandino, F., Carosi, M., Rollo, F., Ronchetti, L., Muti, P. C., Mariani, L., Sindico, S., et al. (2011) · Cancer Causes & Control · doi:10.1007/s10552-011-9757-0 · Cited by 24
Masumoto, N., Fujii, T., Ishikawa, M., Mukai, M., Saito, M., Iwata, T., Fukuchi, T., Kubushiro, K., Tsukazaki, K., & Nozawa, S. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601023 · Cited by 24
Oh, Y. L., Shin, K. J., Han, J., & Kim, D. S. (2001) · Cytopathology · doi:10.1046/j.1365-2303.2001.00302.x · Cited by 24
Mahmud, S. M., Sangwa‐Lugoma, G., Nasr, S. H., Kayembe, P. K., Tozin, R. R., Drouin, P., Lörincz, A. T., Ferenczy, A. S., & Franco, E. L. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.10.031 · Cited by 23
An update review on HPV testing methods for cervical neoplasia
Koliopoulos, G., Valasoulis, G., & Zilakou, E. (2009) · Expert Opinion on Medical Diagnostics · doi:10.1517/17530050802705680 · Cited by 23
Self-citationHerbert, A., Anshu, Gregory, M., Gupta, S. S., & Singh, N. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01990.x · Cited by 21
McAdam, M., Sakita, J., Tarivonda, L., Pang, J., & Frazer, I. H. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013266 · Cited by 21
Siriaunkgul, S., Settakorn, J., Sukpan, K., Srisomboon, J., Suprasert, P., Kasatpibal, N., & Khunamornpong, S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6837 · Cited by 19
Chao, A., Chang, C., Lai, C., Chao, F., Hsu, Y.-H., Chou, H., Huang, H., Jung, S., Lin, C.-T., Cheng, H., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24717 · Cited by 16
Breitenecker, G., Dinges, H. P., Regitnig, P., Wiener, H., & Vutuc, C. (2004) · Cytopathology · doi:10.1111/j.1365-2303.2004.00125.x · Cited by 15
Cost of screening for cancerous and precancerous lesions of the cervix
Méréa, E., Galès, C. L., Cochand‐Priollet, B., Cartier, I., de Crémoux, P., Vacher‐Lavenu, M., Vielh, P. R., & Coste, J. (2002) · Diagnostic Cytopathology · doi:10.1002/dc.10177 · Cited by 15
Kim, J. H., Kim, I.-W., Kim, Y., Park, D. C., Kim, Y. W., Lee, K., Ahn, T.-G., Han, S., & Ahn, W. S. (2013) · Oncology Reports · doi:10.3892/or.2013.2257 · Cited by 12
Detection of Human Telomerase RNA Gene in Cervical Cancer and Precancerous Lesions
Li, Y., Ye, F., Lü, W., Zeng, W.-J., Wei, L., & Xie, X. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181c50c7e · Cited by 12
Paraskevaidis, E., Malamou-Mitsi, V., Koliopoulos, G., Pappa, L., Lolis, E., Georgiou, I. A., & Agnantis, N. J. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6303 · Cited by 12
Self-citationQuincy, B. L., Turbow, D., Dabinett, L. N., Dillingham, R., & Monroe, S. (2012) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2012.717989 · Cited by 11
SNIPER: A Novel Assay for Human Papillomavirus Testing Among Women in Guizhou, China
Belinson, S., Wulan, N., Li, R., Zhang, W., Rong, X., Zhu, Y., Wu, R., & Belinson, J. L. (2010) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181e73092 · Cited by 10
Complementary Procedures in Cervical Cancer Screening in Low Resource Settings
Katyal, S., & Mehrotra, R. (2011) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-011-0067-y · Cited by 10
Junyangdikul, P., Tanchotsrinon, W., Chansaenroj, J., Nilyaimit, P., Lursinsap, C., & Poovorawan, Y. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.2.903 · Cited by 10
Özcan, E. S., Taşkın, S., & Ortaç, F. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2011.597460 · Cited by 8
Idelevich, P., Kristt, D., Schechter, E., Lew, S., Elkeles, A., Terkieltaub, D., Rivkin, I., Bruchim, I., & Fishman, A. (2011) · Diagnostic Cytopathology · doi:10.1002/dc.21729 · Cited by 7
Ma, L., Bian, M., Cheng, J., XIAO, W., Hao, M., Zhu, J. L., Chen, Y., & Liu, J. (2009) · Experimental and Therapeutic Medicine · doi:10.3892/etm_00000031 · Cited by 6
The study of the combination detection of HPV-DNA and p16INK4a in cervical lesions
Huang, M., Huang, S., Deng-qing, L., Nie, X., Li, H., & Jiang, X. (2010) · Medical Oncology · doi:10.1007/s12032-010-9705-y · Cited by 5
Diamantopoulou, S., Spathis, A., Chranioti, A., Anninos, D., Stamataki, M., Chrelias, C., Pappas, A., Panayiotides, I. G., & Karakitsos, P. (2013) · PubMed · Cited by 4
Research works printed but not linked: 9
- McAdam, 2010, Evaluation of a cervical cancer screening program based on HPV testing and LLETZ excision in a low resource setting, PLoS ONE, 5, e13266, 10.1371/journal.pone.0013266 · DOI
- Castle, 2011, Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study, Lancet Oncology, 12, 880, 10.1016/S1470-2045(11)70188-7 · DOI
- Chan, 1999, NASBA and other transcription-based amplification methods for research and diagnostic microbiology, Review Medical Microbiology, 10, 184
- International Agency for research on Cancer, 2005, Cervix Cancer Screening: IARC Handbooks of Cancer Prevention, 10
- IARC working group on the evaluation of carcinogenic risks to humans, 2007, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 90: Human Papilloma viruses
- Kjaer S Long term predictive value of HPV testing (the Danish prospective cohort study) 21st International Human Papillomavirus Conference Mexico City Abstract 339
- Luesley, 2004, NHSCSP Publication No. 20. Colposcopy and Programme Management. Guidelines for the NHS Cervical Screening Programme
- Reitsma JB Rutjes AWS Whiting P Vlassov VV Leeflang MMG Deeks JJ Chapter 9: Assessing methodological quality. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2009 Available from: srdta.cochrane.org/
- Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014
Cited by
Sorted by citations
Arbyn, M., Smith, S. B., Temin, S., Sultana, F., & Castle, P. (2018) · BMJ · doi:10.1136/bmj.k4823 · Cited by 851
Self-citationCervical Cancer: An Overview of Pathophysiology and Management
Johnson, C., James, D., Marzan, A. B., & Armaos, M. (2019) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2019.02.003 · Cited by 386
Interventions targeted at women to encourage the uptake of cervical screening
Everett, T., Bryant, A., Griffin, M. F., Martin-Hirsch, P. P., Forbes, C. A., & Jepson, R. G. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002834.pub2 · Cited by 332
Self-citationSantesso, N. A., Mustafa, R. A., Schünemann, H. J., Arbyn, M., Blumenthal, P. D., Cain, J. M., Chirenje, M., Denny, L. E., Vuyst, H. D., Eckert, L. O., et al. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.07.038 · Cited by 210
Self-citationMustafa, R. A., Santesso, N., Khatib, R., Mustafa, A. A., Wiercioch, W., Kehar, R., Gandhi, S., Chen, Y., Cheung, A., Hopkins, J., et al. (2016) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2015.07.024 · Cited by 199
Self-citation
Metadata
- Authors
- Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A., Schünemann, H., Paraskevaidis, E., & Arbyn, M.
- Affiliations
- General-Maternity District Hospital Helena Venizelou (GR)
- Institut Scientifique de Santé Publique (BE)
- McMaster University (CA)
- Newcastle University (GB)
- Royal Preston Hospital, Lancashire Teaching Hospital NHS Trust; Gynaecological Oncology Unit; Sharoe Green Lane Fullwood Preston Lancashire UK PR2 9HT
- University Hospital of Ioannina (GR)
- Sciensano (Belgium) (BE)
- ORCID
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2017-08-10
- Volume
- 2018
- Issue
- 7
- Pages
- CD008587-CD008587
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- PMC
- PMC6483676
- OpenAlex
- W2171104009
- Cited by
- 494
- References
- 145
- Citations by year
- 2026: 25 · 2025: 71 · 2024: 82 · 2023: 61 · 2022: 70 · 2021: 72 · 2020: 52 · 2019: 40 · 2018: 16
- FWCI
- 3.92
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cochrane Database of Systematic Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- European Commission (603019)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Keywords
- cervical cancer screening, HPV testing, cervical cytology, cervical intraepithelial neoplasia, CIN 2, CIN3, adenocarcinoma in situ, Hybrid Capture 2, HPV genotyping, liquid-based cytology, diagnostic accuracy, sensitivity and specificity, primary screening, test comparison, screening thresholds, bias assessment, QUADAS
- MeSH terms
- Adult, Aged, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Female, Humans, Middle Aged, Precancerous Conditions, Sensitivity and Specificity, Vaginal Smears, Polymerase Chain Reaction, Papillomavirus Infections, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
